July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Morning Overview on MSN
Pairing two long-used Alzheimer’s drugs raised patients’ five-year survival odds
Alzheimer’s patients who took donepezil and memantine together had a measurably higher chance of surviving five years than ...
High doses of the Alzheimer's drug Aricept should be banned because they are no more effective than low doses and have a sharply increased risk of adverse effects, the advocacy group Public Citizen ...
Aricept (donepezil) is a tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover Aricept or its generic version, but the exact coverage and a person’s ...
Japanese drug company Eisai‘s (TYO:4523) bid to extend the patent life of its blockbuster Alzheimer’s drug Aricept with a new skin patch formulation has been dealt a blow by the U.S. Food and Drug ...
Oral medications may be covered by a stand-alone Medicare Part D plan or a Medicare Advantage Prescription Drug (MAPD) plan. Both types of plans are approved by Medicare but administered by private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results